 |
|
|
|
 |
egories |
 |
 |
New Addition |
 |
|
|
 |
Details: |
 |
|
|
Develops and commercializes a vaccine against human chorionic gonadotropin secreting cancers, and synthetic antisense technology to inhibit translation in treating cardiovascular, kidney and viral diseases. Research and manufacturing facilities in Corvallis, Oregon. (Nasdaq: AVII)
|
| URL: |
|
| Title: |
|
| Description: |
Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Biopharmaceuticals - AVI Biopharma, Inc.. Develops and commercializes a vaccine against human chorionic gonadotropin secreting cancers, and synthetic antisense technology to inhibit translation in treating cardiovascular, kidney and viral diseases. |
| Specialized in: |
|
|
 |
|
 |
GenPhar (Popularity: ): Specializes in viral diagnostics, vaccines, and cancer therapy. Includes current research, news releases and contact information.
Pharmos Corporation (Popularity: ): Develops and commercializes products for the central nervous system (CNS), neurological, ophthalmic and other healthcare markets.
BioRexis Pharmaceutical Corp. (Popularity: ): Company with proprietary protein technology for carrier to enhance half-life and efficacy, fused peptide in therapeutic applications, and yeast host ...
Cue Biotech Inc. (Popularity: ): Company focusing on G-protein coupled receptor signaling as targets for therapeutic products. Includes corporate data, partnering and technology overviews, with ...
ConjuChem, Inc. (Popularity: ): Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. ...
Connetics Corporation (Popularity: ): Principally engaged in rapid commercialization of new therapies in the areas of rheumatology and dermatology. Includes product pipeline, investor relations, ...
Generex Biotechnology (Popularity: ): Developed a proprietary technology to orally administer large molecule drugs. These drugs include proteins, peptides, monoclonal antibodies, hormones and vaccines.
Genfit (Popularity: ): Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research.
GlycoTech Corporation (Popularity: ): Research glycobiology company developing diagnostics and therapeutics for cancer and inflammatory diseases based on the interaction of glycoconjugates and their ...
Lybradyn: Microbial Natural Products (Popularity: ): Focused on discovering and developing natural products from living organisms to serve the pharmaceutical and fine chemical industries. Includes explanation ...
|
 |
Popular Sites |
 |
Connetics Corporation (Popularity: ): Principally engaged in rapid commercialization of new therapies in the areas of rheumatology and dermatology. Includes product pipeline, investor relations, ...
GenPhar (Popularity: ): Specializes in viral diagnostics, vaccines, and cancer therapy. Includes current research, news releases and contact information.
ConjuChem, Inc. (Popularity: ): Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. ...
Cue Biotech Inc. (Popularity: ): Company focusing on G-protein coupled receptor signaling as targets for therapeutic products. Includes corporate data, partnering and technology overviews, with ...
BioRexis Pharmaceutical Corp. (Popularity: ): Company with proprietary protein technology for carrier to enhance half-life and efficacy, fused peptide in therapeutic applications, and yeast host ...
|
 |
Related Press |
 |
BioMarin to Present at the JPMorgan 25th Annual Healthcare Conference (Popularity: ): BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a ...
Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates (Popularity: ): Newly published data by Dr. J. Barthelow Classen shows that vaccines are particularly likely to cause diabetes in children with ...
15 common myths about cervical cancer (Popularity: ): U-M experts explain common misconceptions, fears about this largely preventable disease
January 10, 2007 - ANN ARBOR, MI – About ...
DSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract Manufacturer of PER.C6(R) Cell Line Proteins (Popularity: ): DSM Biologics and Crucell N.V. (Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) announced today that they have entered into an agreement ...
DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease (Popularity: ): Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, announced today that after completing its review of safety ...
|
 |
Related Articles |
 |
|
|
 |
|
 |
| |
| | |
|
|
|
© 2003-2008, ABC-Directory.Com. All Rights Reserved
|
|
|
 |
|
 |
|